Insider track record Other Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Lynn Baxter. Director active across 1 company, notably GSK plc. Aggregated, 17 filings have been logged. Activity tracked since 8 January 2026. The latest transaction was disclosed on 9 June 2026 (Purchase). Regulator: RNS (LSE). All data is free.
Declarations 17 total
● President, Europe · Executives · 9 Jun 2026 · GSK plc 14 shares @ £18.8393 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:9614374-0 Ideal exit: 6 Mar 2027 (T+270) ● President, Europe · Executives · 9 Jun 2026 · GSK plc 14 shares @ £18.8393 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:03338973-0058-4811-9fe5-7b22157346a2-0 Ideal exit: 6 Mar 2027 (T+270) ● President, Europe · Executives · 12 May 2026 · GSK plc 12 shares @ £18.6558 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:eaad27f1-a91f-4bc4-815a-149202956de0-0 Ideal exit: 6 Feb 2027 (T+270) ● President, Europe · Executives · 13 Apr 2026 · GSK plc 12 shares @ £21.7083 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:bae2311e-28b0-4835-a894-0209eedccba9-0 Ideal exit: 8 Jan 2027 (T+270) ● President, Europe · Executives · 9 Apr 2026 · GSK plc 0
GB00BN7SWP63⌘ RNS:66208821-3d67-43ba-837e-411f45d449f1-5 Ideal exit: 4 Jan 2027 (T+270) ● President, Europe · Executives · 9 Apr 2026 · GSK plc 32 shares @ £21.3388 0.0000% mcap 0.1% of flow GB00BN7SWP63⌘ RNS:5b5d692c-e307-4a46-a436-f5464b4ee34b-1 Ideal exit: 4 Jan 2027 (T+270) ● President, Europe · Executives · 10 Mar 2026 · GSK plc 12 shares @ £20.7167 0.0% of flow GB00BN7SWP63⌘ RNS:08be650c-10c4-4fa5-9cae-5b89efa04716-0 Ideal exit: 5 Dec 2026 (T+270) ● President, Europe · Executives · 13 Feb 2026 · GSK plc 4,240 shares @ £21.6002 9.6% of flow GB00BN7SWP63⌘ RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-3 ● President, Europe · Executives · 13 Feb 2026 · GSK plc 10,908 shares 0
GB00BN7SWP63⌘ RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-2 ● President, Europe · Executives · 12 Feb 2026 · GSK plc 3,020 shares @ £21.41 6.8% of flow GB00BN7SWP63⌘ RNS:e14ec1ef-e00c-491f-ac5e-002e9669cbba-0 ● President, Europe · Executives · 12 Feb 2026 · GSK plc 32,757 shares @ £21.50 74.0% of flow GB00BN7SWP63⌘ RNS:586c5c74-54b9-425a-a37c-ba21836ecce7-2 ● President, Europe · Executives · 9 Feb 2026 · GSK plc 4,084 shares @ £21.9082 9.4% of flow GB00BN7SWP63⌘ RNS:b9b234f0-beb3-4926-b79e-ff2ce727c5dd-1 ● President, Europe · Executives · 9 Feb 2026 · GSK plc 10,050 shares 0
GB00BN7SWP63⌘ RNS:b9b234f0-beb3-4926-b79e-ff2ce727c5dd-0 ● President, Europe · Executives · 10 Feb 2026 · GSK plc 12 shares @ £21.7917 0.0% of flow GB00BN7SWP63⌘ RNS:f7024c14-f781-4e48-a904-495085bc7ca2-0 Ideal exit: 7 Nov 2026 (T+270) ● President, Europe · Executives · 8 Jan 2026 · GSK plc 0
GB00BN7SWP63⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-10 Ideal exit: 5 Oct 2026 (T+270) ● President, Europe · Executives · 8 Jan 2026 · GSK plc 32 shares @ £18.9434 0.1% of flow GB00BN7SWP63⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-1 Ideal exit: 5 Oct 2026 (T+270) ● President, Europe · Executives · 12 Jan 2026 · GSK plc 12 shares @ £18.9325 0.0% of flow GB00BN7SWP63⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-41 Ideal exit: 9 Oct 2026 (T+270) About Lynn Baxter Lynn Baxter is President, Europe at GSK plc (XLON). She has 17 filings in total, and in the recent sampled filings, buys amount to EUR 3501 and sells to EUR 208037, over the period from 2026-01-13 to 2026-06-12, with a modal transaction nature of Purchase.